Document:

Exhibit 10.2

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT
(the “Agreement”), dated June 4, 2020, is entered into by and between Acacia Research Group LLC, a Texas limited
liability company (the “Company”), and Meredith Simmons (“Executive”), on the following terms
and conditions.

 

BACKGROUND

 

WHEREAS, the
Company and Executive desire to enter into this Agreement, subject to the terms and conditions as set forth below.

 

NOW, THEREFORE,
in consideration of the foregoing and the mutual covenants set forth herein, the Company and Executive, intending to be legally
bound, hereby agree as follows:

 

1.Definitions. For purposes
of this Agreement, the following terms shall have the following meanings:

 

a.               
“ARC” shall mean Acacia Research Corporation, a Delaware corporation.

 

b.              
“Board” shall mean the Board of Directors of ARC.

 

c.               
“Cause” shall mean Executive’s (i) refusal to substantially perform her duties hereunder; (ii)
breach any of her material obligations under this Agreement; (iii) willful misconduct or gross negligence in the performance of
her duties; (iv) conviction of or plea of guilty or nolo contendre to any felony; or (v) embezzlement or theft of any of
the Company’s funds or assets or commission of any act of fraud with respect to any aspect of the Company’s business.

 

2.Position and Responsibilities. Executive
shall be employed and serve as General Counsel of the Company. Executive agrees that, at all times during her employment
hereunder, Executive shall be subject to and comply with the Company’s personnel rules, policies and procedures,
including but not limited to ARC’s and the Company’s Insider Trading Policy (attached hereto as Exhibit A),
Sexual Harassment Policy (attached hereto as Exhibit B), Executive Handbook (which has been provided to Executive) and
Executive Officer Stock Ownership Guidelines (attached hereto as Exhibit C), in each case, as may be modified from
time to time. Executive shall devote her full working time and efforts to the Company’s business to the exclusion of
all other employment or active participation in other business interests, unless otherwise consented to in writing by the
Company. This shall not preclude Executive from (a) devoting time to personal and family endeavors or investments, (b)
serving on community and civic boards, (c) participating in industry or trade associations, or (d) serving on a board of a
public or private company that does not directly compete with the Company; provided, that (x) such activities do not
materially interfere with Executive’s duties to the Company or create a conflict of interest, and (y) the Board shall
approve Executive’s service on any board of directors.

 

3.Employment. Executive’s employment
with the Company may be terminated by the Company or Executive upon thirty (30) days’ written notice to the other
party, for any reason. This arrangement may not be changed during Executive’s employment, unless agreed to in writing
by the Compensation Committee of the Board (the “Compensation Committee”).

 

4.Compensation. For all services rendered by
Executive pursuant to this Agreement, the Company shall pay Executive, subject to her adherence to all of the terms of this Agreement,
and Executive shall accept as full compensation hereunder, the following:

 

a.                 
Salary. The Company shall pay Executive an annual salary (the “Base Salary”) of $400,000. The
Base Salary shall be subject to all appropriate federal and state withholding taxes and shall be payable bi-weekly, in accordance
with the normal payroll procedures of the Company. The Base Salary shall be subject to an annual review by the Compensation Committee.
In the event of an adjustment to the Base Salary, the term “Base Salary” shall refer to the adjusted amount.

 

b.                
Annual Bonus, Executive shall be eligible for annual cash incentive compensation (the “Annual Bonus”)
25-75% of Base Salary] as shall be determined by the Board in accordance with annual performance objectives established by the
Board on an annual basis with a target of 50% of Base Salary. The Annual Bonus, if any, shall be paid to Executive in the same
manner and at the same time that other senior-level executives of the Company receive their annual bonus awards, as determined
by the Board or the Compensation Committee. In order to be eligible for an Annual Bonus, Executive must be in good standing with
the Company. The Annual Bonus shall be subject to all appropriate federal and state withholding taxes.

 

 

 

    	 	1	 

     

    

 

c.                 
Restricted Stock Units, As of the date hereof, the Executive will be granted 80,000 restricted stock units of the
Company (Nasdaq: ACTG) on the terms and conditions (including the vesting terms) set forth on Exhibit RS (the “Initial Equity
Grant”).

 

d.                
Benefits and Perquisites, The Company shall make benefits available to Executive, including, but not limited to,
vacation and holidays, sick leave, health insurance, and the like, to the extent and on the terms made available to other similarly
situated employees of the Company. This provision does not alter the Company’s right to modify or eliminate any employee
benefit and does not guarantee the continuation of any kind or level of benefits. All such benefits shall cease upon the termination
of Executive’s employment under this Agreement.

 

e.                 
Expenses; Travel, The Company shall reimburse Executive for all reasonable out-of-pocket business and travel expenses
incurred in connection with the performance of Executive’s duties or professional activities on behalf of the Company in
accordance with the Company’s reimbursement policies.

 

5.Termination of Employment. In the event of
a termination of the Executive’s employment by the Company without Cause (and other than by reason of the Executive’s
disability), subject to the Executive’s (a) execution and non-revocation of a general release of claims in a form acceptable
to the Company within 55 days following the Executive’s date of termination and (b) compliance with the provisions of this
Agreement, the Executive shall be entitled to continued payment of the Base Salary for a period of 90 days following the date
of termination in accordance with the normal payroll schedule applicable to other similarly situated senior executives of the
Company.

 

6.       Confidentiality.

 

a.               
Confidential Information, The Company and Executive recognize that Executive will acquire certain confidential and
proprietary information relating to the Company’s business and the business of the Company’s affiliates. Such confidential
and proprietary information is information that derives independent economic value, actual or potential, from not being generally
known to the public or to other persons who can obtain economic value from its disclosure or use, and is the subject of efforts
that are reasonable under the circumstances to maintain its secrecy (“Confidential Information”). Confidential
Information may include, without limitation, the following: business plans, projections, planning and strategies, marketing plans,
materials, pricing, programs and related data, product information, services, budgets, acquisition plans, the names or addresses
of any employees, independent contractors or customers, licensing strategy, statistical data, financial information or arrangements,
manuals, forms, techniques, know-how, trade secrets, software, any method or procedure of the Company’s business, whether
developed by the Company or developed, or contributed to, by Executive during the course of Executive’s employment, or made
available to Executive by the Company or any of the Company’s affiliates in the course of Executive’s employment, or
any market development, research or expansion projects, business systems and procedures and other confidential business and proprietary
information. Confidential Information may be contained in written materials, verbal communications, the unwritten knowledge of
employees, or any other tangible medium, such as tape, computer, or other means of electronic storage of information.

 

b.              
Obligation of Confidentiality, Executive acknowledges and agrees that all of the Confidential Information constitutes
special, unique and valuable assets of the Company and trade secrets, the disclosure of which would cause irreparable harm and
substantial loss to the Company and its affiliates. In view of the foregoing, Executive agrees that at no time will Executive,
directly or indirectly, and whether during or after his or her employment with the Company, use, reveal, disclose or make known
any Confidential Information without specific written authorization from or written direction by the Company. Executive further
agrees that, immediately upon termination or expiration of his or her employment for any reason whatsoever, or at any time upon
request by the Company, Executive will return to the Company all Confidential Information. Notwithstanding the foregoing, any restriction
on Executive’s use, disclosure, or conveyance of Confidential Information shall not apply to (i) any Confidential Information
that enters the public domain through no fault of Executive’s or any person affiliated with Executive; (ii) any Confidential
Information that Executive is required to disclose pursuant to applicable law or legal process, an order of a court of competent
jurisdiction or a government agency having appropriate authority, solely to the extent necessary to comply with such order; and
(iii) any use or disclosure, during the course of Executive’s service with the Company of Confidential Information made necessary
by the proper conduct of the business of the Company and consistent with the instructions of the Company. Nothing herein shall
prohibit Executive from providing information in connection with: (a) any disclosure of information required by law or legal process;
(b) reporting possible violations of federal or state law or regulation to any governmental agency, commission or entity or self-regulatory
organization (collectively “Government Agencies”) (c) filing a charge or complaint with Government Agencies; (d) making
disclosures that are protected under the whistleblower provisions of federal or state law or regulation (collectively the “Whistleblower
Statutes”); or (e) from responding to any inquiry from, or assisting in any inquiry, investigation or proceeding brought
by Government Agencies in connection with (a) through (e).

 

 

 

    	 	2	 

     

    

 

7.              
Intellectual Property. Executive agrees that any and all discoveries, concepts, ideas, inventions, writings, plans,
articles, devices, products, designs, treatments, structures, processes, methods, formulae, techniques and drawings, and improvements
or modifications related to the foregoing that are in any way related to the Company’s patent portfolios or any other intellectual
property owned by the Company or its affiliates, whether patentable, copyrightable or not, which are made, developed, created,
contributed to, reduced to practice, or conceived by Executive, whether solely or jointly with others, in connection with Executive’s
employment with the Company (collectively, the “Intellectual Property”) shall be and remain the exclusive property
of the Company, and, to the extent applicable, a “work made for hire,” and the Company shall own all rights, title
and interests thereto, including, without limitation, all rights under copyright, patent, trademark, statutory, common law and/or
otherwise. By Executive’s execution of this Agreement, Executive hereby irrevocably and unconditionally assigns to the Company
all right, title and interest in any such Intellectual Property. Executive further agrees to take all such steps and all further
action as the Company may reasonably request to effectuate the foregoing, including, without limitation, the execution and delivery
of such documents and applications as the Company may reasonably request to secure the rights to Intellectual Property worldwide
by patent, copyright or otherwise to the Company or its successors and assigns. Executive further agrees promptly and fully to
disclose any Intellectual Property to the officers of the Company and to deliver to such officers all papers, drawings, models,
data and other material (collectively, the “Material”) relating to any Intellectual Property made, reduced to
practice, developed, created or contributed to by Executive and, upon termination, or expiration of his or her employment with
the Company, to turn over to the Company all such Material. Any intellectual property which was developed by Executive prior to
Executive’s first date of employment with the Company, or which is developed by Executive during or after the termination
of this Agreement and is not in any way related to any of the Company’s or any of its affiliates’ intellectual property,
shall be owned by Executive.

 

8.              
Covenants.

 

a.       Exclusive
Service; Non-Solicitation, During the term of Executive’s employment, Executive agrees not to perform services for any
other entity, group or individual if such service would be in conflict with or interfere in any way with the Company’s business
interests (as reasonably determined by the Company). During the term of Executive’s employment and for a period of 12 months
after termination of Executive’s employment for any reason, Executive shall not (a) solicit for employment and then employ
any employee of the Company or any of its affiliates or any person who is an independent contractor involved with the Company or
any of its affiliates (or any person who was during the prior six months an employee or independent contractor of the Company or
any of its affiliates), (b) pursue or otherwise solicit any Customer or Investment Opportunity of the Company or any of its affiliates,
or (c) induce, attempt to induce or knowingly encourage any Customer or Investment Opportunity of the Company or any of its affiliates
to divert any business or income from the Company or any of its affiliates or to stop or alter the manner in which they are then
doing business with the Company or any of its affiliates. In addition, in the event of the termination of Executive’s employment
for any reason, Executive, for a period of 18 months following Executive’s termination of employment for any reason, will
not serve as a director, officer, employee or consultant to any public company engaged in the business of acting as a patent assertion
entity (“PAE”); provided that (i) Executive may be employed by or provide services to an affiliated group that has
a business unit that acts as a PAE,

 

which business unit comprises no more than
fifteen percent (15%) of such affiliated group’s overall business as measured by revenue, provided that Executive does not
provide any direct services to the business unit (for the avoidance of doubt, it shall not be a violation of this Agreement for
Executive to render services to a different business unit or to serve the parent of such business unit), and comply with Executive’s
obligations with respect to the Company’s Confidential Information and (ii) Executive may become employed by or provide services
to any private equity fund, hedge fund, or other similar investment vehicle that invests in or holds a position in a public entity
that acts as a PAE, provided that Executive’s services to such investment vehicle or its managers or advisors do not involve
investment or management decisions with respect to any of such investment vehicle’s public portfolio companies engaged as
PAEs and Executive does not use any of the Company’s Confidential Information. The term “Customer” shall
mean any individual or business firm that was or is a customer or client of, or one that was or is a party in an investor agreement
with, or whose business was actively solicited by, the Company or any of its affiliates at any time, regardless of whether such
customer was generated, in whole or in part, by Executive’s efforts. The term “Investment Opportunity”
means any opportunity in which the Company or any of its affiliates or subsidiaries at any time sought to invest, regardless of
whether such opportunity was generated, in whole or in part, by Executive’s efforts.

 

b.                
Return of the Company’s Property, Upon the termination of Executive’s employment in any manner, Executive
shall immediately surrender to the Company all lists, books and records of, or in connection with, the Company’s business,
and all other property belonging to the Company.

 

c.                 
Cooperation, During the term of this Agreement and thereafter, Executive agrees to cooperate with the Company and
its affiliates, agents, accountants and attorneys concerning any matter with which Executive was involved during Executive’s
employment. Such cooperation shall include, but not be limited to, providing information to, meeting with and reviewing documents
provided by the Company and its affiliates, agents, accountants and attorneys during normal business hours or other mutually agreeable
hours upon reasonable notice and being available for depositions and hearings, if necessary and upon reasonable notice. If Executive’s
cooperation is required after the termination of Executive’s employment, the Company shall reimburse Executive for any reasonable
out of pocket expenses incurred in performing Executive’s obligations hereunder.

 

 

 

    	 	3	 

     

    

 

d.                
Non-Disparagement. During the term of this Agreement and thereafter, Executive shall not make any statements (whether
written, electronic or oral) that disparage, denigrate, malign or criticize the Company or any of its affiliates, businesses, products,
directors, officers or employees. Notwithstanding the foregoing, in no event shall the provisions of this Section 7(d) prohibit
Executive from making truthful statements to the extent required by law or legal process.

 

9.       General Provisions.

 

a.       Successors
and Assigns, The rights of the Company under this Agreement may, without the consent of Executive, be assigned by the
Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity that at any time,
whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business
of the Company. The Company will require any successor (whether direct or indirect, by purchase, merger or otherwise) to all
or substantially all of the business or assets of the Company expressly to assume and to agree to perform this Agreement in
the same manner and to the same extent that the Company would be required to perform it if no such succession had taken
place; provided, however, that no such assumption shall relieve the Company of its obligations hereunder. As used in
this Agreement, the “Company” shall mean the Company as hereinbefore defined and any successor to its
business and/or assets as aforesaid that assumes and agrees to perform this Agreement by operation of law or otherwise.
Executive shall not be entitled to assign any of Executive’s rights or obligations under this Agreement. This Agreement
shall inure to the benefit of and be enforceable by Executive’s personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. If Executive should die while any amount is at such
time payable to Executive hereunder, all such amounts, unless otherwise provided herein, shall be paid in accordance with the
terms of this Agreement to Executive’s devisee, legatee, or other designee or, if there be no such designee, to
Executive’s estate.

 

b.                
Remedies, Each of the parties to this Agreement will be entitled to enforce its rights under this Agreement specifically,
to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights existing in its
favor. The parties agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this
Agreement and that any party may in its sole discretion apply to any court of law or equity of competent jurisdiction for injunctive
relief without the need for an undertaking in order to enforce or prevent any violations of the provisions of this Agreement.

 

c.                 
Severability and Reformation, The parties intend all provisions of this Agreement to be enforced to the fullest extent
permitted by law. If, however, any provision of this Agreement is held to be illegal, invalid, or unenforceable under present or
future law, such provision shall be fully severable, and this Agreement shall be construed and enforced as if such illegal, invalid,
or unenforceable provision were never a part hereof and the remaining provisions shall remain in full force and effect. Moreover,
any provision so affected shall be limited only to the extent necessary to bring the Agreement within the applicable requirements
of law.

 

d.                
Governing Law and Venue, This Agreement is to be governed by and construed in accordance with the laws of the State
of New York applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws
principles thereof. Any suit brought and any and all legal proceedings to enforce this Agreement whether in contract, tort, equity
or otherwise, shall be brought in the state or federal courts sitting in Manhattan, New York, the parties hereto hereby waiving
any claim or defense that such forum is not convenient.

 

e.                 
Arbitration of Disputes,

 

(a)       Agreement
to Arbitrate. The parties hereby agree that any and all disputes, claims or controversies arising out of or relating to
this Agreement, the employment relationship between the parties, or the termination of the employment relationship, that are
not resolved by their mutual agreement shall be resolved by final and binding arbitration by a neutral arbitrator. This
agreement to arbitrate includes any claims that the Company may have against Executive, or that Executive may have against
the Company and any of its affiliates or its or their officers, directors, employees, agents and representatives.

 

(b)            
Covered Claims. The claims covered by this agreement to arbitrate include, but are not limited to, claims for: wrongful
termination; breach of any contract or covenant, express or implied; breach of any duty owed to Executive by the Company or to
the Company by Executive; personal, physical or emotional injury; fraud, misrepresentation, defamation, and any other tort claims;
wages or other compensation due; penalties; benefits; reimbursement of expenses; discrimination or harassment, including but not
limited to discrimination or harassment based on race, sex, color, pregnancy, religion, national origin, ancestry, age, marital
status, physical disability, mental disability, medical condition, or sexual orientation; retaliation; violation of any local,
state, or federal constitution, statute, ordinance or regulation (as originally enacted and as amended), including but not limited
to Title VII of the Civil Rights Act of 1964, Age Discrimination in Employment Act of 1967, Americans With Disabilities Act, Fair
Labor Standards Act, Executive Retirement Income Security Act, Immigration Reform and Control Act, Consolidated Omnibus Budget
Reconciliation Act, Family and Medical Leave Act, California Fair Employment and Housing Act, California Family Rights Act, California
Labor Code, California Civil Code, and the California Wage Orders or similar laws of other states. This Agreement shall not apply
to any dispute if an agreement to arbitrate such dispute is prohibited by law.

 

 

 

    	 	4	 

     

    

 

(c)            
Arbitration Process. The Parties further agree that any arbitration shall be conducted before one neutral arbitrator
selected by the parties and shall be conducted under the Employment Arbitration Rules of the JAMS (“JAMS Rules”)
then in effect. Executive may obtain a copy of the JAMS Rules by accessing the JAMS website at https://www.jamsadr.com, or by requesting
a copy from the President of the Board. By signing this Agreement, Executive acknowledges that he or she has had an opportunity
to review the JAMS Rules before signing this Agreement. The arbitration shall take place in Manhattan, New York. The arbitrator
shall have the authority to order such discovery by way of deposition, interrogatory, document production, or otherwise, as the
arbitrator considers necessary to a full and fair exploration of the issues in dispute, consistent with the expedited nature of
arbitration. The arbitrator is authorized to award any remedy or relief available under applicable law that the arbitrator deems
just and equitable, including any remedy or relief that would have been available to the parties had the matter been heard in a
court. Nothing in this Agreement shall prohibit or limit the parties from seeking provisional remedies under California Code of
Civil Procedure section 1281.8 or similar state and local laws, including, but not limited to, injunctive relief from a court of
competent jurisdiction. The arbitrator shall have the authority to provide for the award of attorney’s fees and costs if
such award is separately authorized by applicable law. Executive shall not be required to pay any cost or expense of the arbitration
that she would not be required to pay if the matter had been heard in a court. The decision of the arbitrator shall be in writing
and shall provide the reasons for the award unless the parties agree otherwise. The arbitrator shall not have the power to commit
errors of law or legal reasoning and the award may be vacated or corrected on appeal to a court of competent jurisdiction for any
such error.

 

(d)            
Federal Arbitration Act. This agreement to arbitrate shall be enforceable under and subject to the Federal Arbitration
Act, 9 U.S.C. Sections 1, et. seq.

 

f.                 
Entire Agreement, Amendment and Waiver, This Agreement contains the entire understanding and agreement between the
parties, and supersedes any other agreement between the Company and Executive, whether oral or in writing, with respect to the
subject matter hereof. This Agreement may not be altered or amended, nor may any of its provisions be waived, except by a writing
signed by both parties hereto or, in the case of an asserted waiver, by the party against whom the waiver is sought to be enforced.
Waiver of any provision of this Agreement, or any breach thereof, shall not be deemed to be a waiver of any other provision or
any subsequent alleged breach of this Agreement.

 

g.                
Clawback, Stock Ownership and Holding Period Requirements. Notwithstanding any other provision in this Agreement to
the contrary, Executive shall be subject to the written policies of the Company’s Board of Directors applicable to Company
executives, relating to recoupment or “clawback” of incentive compensation.

 

h.                
Survival and Counterparts, The provisions of Section 1 (Definitions), Section 5 (Confidentiality), Section 6 (Intellectual
Property), Section 7 (Covenants) and Section 8 (General Provisions) of this Agreement shall survive the termination of this Agreement.
This Agreement may be executed in counterparts, with the same effect as if both parties had signed the same document. All such
counterparts shall be deemed an original, shall be construed together and shall constitute one and the same instrument. This Agreement
shall supersede any prior or other agreement governing the subject matter hereof.

 

[Remainder of Page Intentionally Left
Blank; Signature Page Follows]

 

 

 

    	 	5	 

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date first above written.

 

Company:

 

	 	 ACACIA RESEARCH GROUP LLC

 

 

 By: _____________________
Name:

Title:

	 	 
	 	 Executive:

 

 

 

_________________________

Meredith Simmons

 

 

 

 

    	 	6	 

     

    

 

EXHIBIT A

 

INSIDER TRADING POLICY

 

See attached.

 

 

 

 

    	 	7	 

     

    

 

 

 

INSIDER TRADING POLICY

 

Statement of Policies and Procedures

Governing Material Nonpublic Information and

 

The Prevention of Insider Trading

 

Updated: June 13, 2019

 

I.               
Purpose of this Policy

 

The purchase or sale of securities while
possessing material nonpublic (“inside”) information or the disclosure of inside information (“tipping”)
to others who may trade in such securities is sometimes referred to as “insider trading” and is prohibited by federal
and state securities laws. As an essential part of your work, you may have access to material nonpublic information about Acacia
Research Corporation and/or its subsidiaries (including information about other companies with which Acacia does, or may do, business).
When we refer in this Policy to “Acacia” or the “Company,” we are referring to Acacia Research Corporation
and all its subsidiaries and divisions worldwide.

 

This Insider Trading Policy (the “Policy”)
was adopted by Acacia Research Corporation’s Board of Directors on February 1, 2019 to prevent illegal insider trading and
to avoid even the appearance of improper conduct on the part of any Company director, officer, employee or contractor. This Policy
is designed to protect and further the reputation of Acacia for integrity and ethical conduct. Remember, however, the ultimate
responsibility for complying with the securities laws, adhering to this Policy and avoiding improper transactions rests with you.
It is imperative that you use your best judgment.

 

II.             
Penalties for Insider Trading

 

The penalties for violating the insider
trading laws include imprisonment, disgorgement of profits gained or losses avoided, civil fines of up to three times the profit
gained or loss avoided, and criminal fines of up to $5.0 million for individuals and $25.0 million for entities. Individuals and
entities considered to be “control persons”1 who knew or recklessly disregarded the fact that a “controlled
person” was likely to engage in insider trading may be civilly liable for the greater of (i) $1 million or (ii) three times
the amount of the profit gained or loss avoided. Under some circumstances, individuals who trade on inside information may also
be subjected to private civil lawsuits. Moreover, as the material nonpublic information of Acacia is the property of the Company,
trading on or tipping Acacia’s confidential information could result in serious employment sanctions, including dismissal.

 

 

__________

1 A
“control person” is an entity or person who directly or indirectly controls another person, and could include the
Company, its directors and officers.

 

 

 

    	 	8	 

     

    

 

You should be aware that stock market surveillance
techniques are becoming more sophisticated all the time, and the chance that federal authorities will detect and prosecute even
a small insider trading violation is a significant one.

 

Employees who violate this Policy may be
subject to disciplinary action by the Company, including dismissal for cause. Any exceptions to the Policy, if permitted, may only
be granted by the Compliance Officer and must be provided before any activity contrary to the above requirements takes place.

 

III.       Scope
and Applicability

 

A.               
Covered Persons. This Policy applies to Acacia’s Board of Directors and to all employees and contractors
within all of Acacia’s operations worldwide. All persons covered by this Policy are referred to as “Covered Persons.”
This Policy also applies to family members and domestic partners who share a Covered Person’s household, and any other individual
whom the Compliance Officer may designate as a Covered Person because he or she has access to material nonpublic information concerning
the Company.

 

B.                
Covered Securities and Transactions. This Policy applies to all transactions in the Company’s equity securities,
including common stock and any other type of securities that the Company may issue, such as preferred stock, notes, bonds, convertible
debentures and warrants, and exchange-traded options (including puts and calls) and other derivative securities. This Policy applies
to sales, purchases, gifts, exchanges, pledges, options, hedges, puts, calls and short sales.

 

This Policy applies to all investment decisions
you make regarding Company securities. For example, if you have the power to direct the purchase or sale of Company securities
by virtue of your position as a director or officer of a corporation or non-profit organization, or as a trustee of a trust or
executor of an estate, then all transactions in Company securities on behalf of the corporation, organization, trust or estate
are covered by this Policy.

 

This Policy also applies to trading in securities
of another company if you learn material nonpublic information about that company in the course of your employment or association
with Acacia.

 

C.               
Delivery of the Policy; Certifications. This policy will be delivered to all Covered Persons upon its adoption by the
Company, and to all new directors, employees and where appropriate, contractors, at the commencement of their employment or service
with the Company. Thereafter, the Policy shall be distributed annually. All Covered Persons must certify their understanding of,
and intent to comply with, this Policy and send the original to the Company’s Legal Department. A copy of the certification
that all Covered Persons must sign is attached hereto as Exhibit A,

 

IV.       Definitions

 

A.               
Insider Trading. In general, “insider trading” occurs when a person purchases or sells a security while
in possession of inside information in breach of a duty of trust or confidence owed directly or indirectly to the issuer of the
security, the issuer’s stockholders or the source of the information. “Inside information” is information which
is considered both “material” and “nonpublic.” Insider trading is a crime, and it is strictly prohibited
by this Policy.

 

B.                
Materiality. A fact is considered “material” if there is a substantial likelihood that a reasonable investor
would consider it important in making a decision to buy, hold or sell securities or if disclosure of the information would be expected
to significantly alter the total mix of the information in

 

the marketplace about the issuer of the security. Material information
can be either good or bad and is not limited to financial information. While it is impossible to list all types of information
that might be deemed “material” under particular circumstances, information dealing with the following subjects affecting
the Company is generally considered to be material:

 

		·	projections of future earnings, losses or financial liquidity problems;

 

		·	anticipated or actual financial results of the Company for the quarter and/or year;

 

 

 

    	 	9	 

     

    

 

		·	news of a pending or proposed joint venture, merger, acquisition, tender offer,

 

divestiture, recapitalization, strategic alliance, licensing
arrangement or purchase or sales of substantial assets;

 

		·	news of a significant sale or disposition or write-downs of assets;

 

		·	new major contracts, strategic partners, suppliers, customers or loss thereof;

 

		·	change in debt ratings;

 

		·	changes in dividend policies or amounts, or the declaration of a stock split;

 

		·	offerings of additional securities or financing developments;

 

		·	changes in senior management;

 

		·	major changes in accounting methods or policies;

 

		·	cybersecurity risks and incidents, including vulnerabilities and breaches;

 

		·	major personnel changes, labor disputes or negotiations; and

 

		·	significant litigation or government investigations or the resolution thereof.

 

C.       Nonpublic
Information. Information is “nonpublic” if it has not been widely disclosed

 

to the general public through major newswire services, national
news services and financial news services, or through filings with the Securities & Exchange Commission (“SEC”).
For purposes of this Policy, information will be considered public, i.e., no longer “nonpublic,” after the close
of trading on the second full trading day following the Company’s widespread release of the information.

 

Nonpublic information may include:

 

		·	information available to a select group of analysts or brokers or institutional investors;

 

		·	undisclosed facts that are the subject of rumors, even if the rumors are widely circulated; and

 

		·	information that has been entrusted to the Company on a confidential basis until a public announcement of the information has
been made and enough time has elapsed for the market to respond to a public announcement of the information (normally two trading
days).

 

D.       Tipping.
“Tipping” is the disclosure of material nonpublic information concerning the Company or its securities to an outside
person. Providing insider information to anyone who thereafter trades on the basis of that information may subject both you (the
“tipper”) and the other person (the “tippee”) to insider trading liability.

 

V.       Prohibited
Activities

 

A.       Prohibitions.
Except for limited exceptions described below, the following activities are prohibited under this Policy:

 

		1.	No Covered Person may purchase, sell, transfer or effectuate any other transaction in Company securities while in possession
of material nonpublic information concerning the Company or its securities. This prohibition includes sales of shares received
upon exercise of stock options or upon vesting of Restricted Stock Units and Awards, and shares held in the Company’s 401(k)
plan.

 

 

 

    	 	10	 

     

    

 

		2.	No Covered Person may “tip” or disclose material nonpublic information concerning the Company or its securities
to any outside person (including family members, affiliates, analysts, investors, members of the investment community and news
media). Should a Covered Person inadvertently disclose such information to an outsider, the Covered Person must promptly inform
the Compliance Officer regarding this disclosure. The Company will take steps necessary to preserve the confidentiality of the
information, including requiring the outsider to agree in writing to comply with the terms of this Policy and/or sign a confidentiality
agreement.

 

		3.	No Covered Person may purchase Company securities on margin, hold Company securities in a margin
account, or otherwise pledge Company securities as collateral for a loan because, in the event of a margin call or default on the
loan, the broker or lender could sell the shares at a time when the Covered Person is in possession of material nonpublic information,
resulting in liability for insider trading. In addition, pledging of securities by Covered Persons, including margin arrangements,
can be perceived to undermine the alignment of their interests and incentives with the long-term interests of other stockholders.

 

		4.	Short-term and speculative trading in Company securities, as well as hedging and other derivative transactions involving Company
securities, can create the appearance of impropriety and may become the subject of an SEC investigation, particularly if the trading
occurs before a major Company announcement or is followed by unusual activity or price changes in the Company’s stock. These
types of transactions can also result in inadvertent violations of insider trading laws and/or liability for short-swing profits
under Section 16(b) of the Securities Exchange Act of 1934.2 Therefore, it is the Company’s policy to prohibit
the following activities, even if you are not in possession of material nonpublic information:

 

 

__________

2 Under Section
16(b) of the Securities Exchange Act of 1934, directors and executive officers of the Company are subject to liability for
any “short-swing” profits realized from a purchase and sale, or sale and purchase of equity securities of the
Company within any period of less than six months.

 

 

 

    	 	11	 

     

    

 

		(a)	No Covered Person may trade in any interest or position relating to the future price of Company securities, such as put or
call options or other derivatives, or short sale of Company securities.

 

		(b)	No Covered Person may hedge Company securities. A “hedge” is a transaction designed to offset or reduce the risk
of a decline in the market value of an equity security, and can include, but is not limited to, prepaid variable forward contracts,
equity swaps, collars, and exchange funds.

 

		(c)	Covered Persons may not trade in securities of the Company on an active basis, including short
term speculation.2

 

		5.	No Covered Person may trade in securities of another company if the Covered Person is in possession of material nonpublic information
about that other company which the Covered Person learned in the course of their work for Acacia.

 

B.       Exceptions
to Prohibited Activities. Prohibitions in trading securities under this Policy do not include:

 

		1.	The investment of 401(k) plan contributions in a Company stock fund in accordance with the terms
of the Company's 401(k) plan. However, any changes in your investment election regarding the Company’s stock are subject
to trading restrictions under this Policy.

 

		2.	The purchase of Company stock through periodic, automatic payroll contributions to the Company's
Employee Stock Purchase Plan (“ESPP”), if and when such ESPP is adopted. However, electing to enroll in the ESPP, making
any changes in your elections under the ESPP and selling any Company stock acquired under the ESPP are subject to trading restrictions
under this Policy.

 

		3.	The exercise of vested employee stock options, either on a “cash for stock” or “stock for stock” basis,
where no Company stock is sold to fund the option exercise3.

 

		4.	The receipt of Company stock upon vesting of Restricted Stock Units and Awards, as well as the
withholding of Company stock by the Company in payment of tax obligations.

 

		5.	Company securities purchased or sold under a Company authorized Rule 10b5-1 Trading Plan (see Section X below).

 

		6.	Transfers of Company stock by a Covered Person into a trust for which the Covered Person is a trustee, or from the trust back
into the name of the Covered Person.

 

__________

3
While vested employee stock options may be exercised at any time under this Policy, the sale of any stock acquired through such
exercise is subject to this Policy.

 

 

 

    	 	12	 

     

    

 

VI.       Company
Compliance Officer

 

The Compliance Officer may designate one
or more individuals to perform the Compliance Officer’s duties. The determinations of the Compliance Officer under this Policy
are final.

 

The duties of the Compliance Officer include, but are not limited
to, the following:

 

		1.	assisting with implementation and enforcement of this Policy;

 

		2.	circulating this Policy to all employees and ensuring that this Policy is amended as necessary to remain up-to-date with insider
trading laws;

 

		3.	pre-clearing all trading in securities of the Company by Covered Persons in accordance with the procedures set forth in Section
VIII below; and

 

		4.	providing approval of any Rule 10b5-1 plans under Section X below and any prohibited transactions under Section V above.

 

		5.	providing a reporting system with an effective whistleblower protection mechanism.

 

VII. Confidentiality
of Information Relating to the Company

 

A.               
Access to Information. Risk of insider trading violations by individuals affiliated with the Company can be substantially
limited by restricting the pool of individuals with access to material nonpublic information to the greatest extent possible. Access
to material nonpublic information about the Company, including Acacia’s business, earnings and prospects, should be limited
to officers, directors and employees of the Company on a need-to-know basis. In addition, such information should not be communicated
to anyone outside of the Company, unless such person has signed an appropriate confidentiality agreement. When communication of
material nonpublic information about the Company to employees becomes necessary, all directors, officers and employees must take
care to emphasize the need for confidential treatment of such information and adherence to the Company’s policies with regard
to confidential information.

 

B.                
Disclosure of Information. Material nonpublic Company information is the property of Acacia and the confidentiality
of this information must be strictly maintained within the Company. Only the Chief Executive Officer and the Chief Financial Officer
are authorized to disclose material nonpublic information about the Company to the public, members of the investment community
(including analysts) or to stockholders, unless one of these officers has expressly authorized disclosure by another employee in
advance. All inquiries regarding the Company should be directed to the Chief Executive Officer or to the Chief Financial Officer
and no other comment should be provided.

 

VIII. Pre-Clearance
Required for Trading by Covered Persons

 

All Covered Persons must pre-clear planned transactions in Company
securities as provided below:

 

		1.	The Covered Person proposing to effectuate a trade or other transaction in Company securities must notify the Compliance Officer
in writing of the amount and nature of the proposed transaction no earlier than two business days prior to the proposed transaction
date.

 

		2.	The Covered Person proposing to effectuate such trade or other transaction must certify to the Compliance Officer in writing
that he or she is not in possession of material nonpublic information concerning the Company or its securities.

 

		3.	The Compliance Officer must approve the proposed trade or other transaction in writing.

 

 

 

    	 	13	 

     

    

 

		4.	Note: If the transaction order is not placed within ten (10) business days after receiving clearance, clearance for
the transaction must be re-requested since circumstances may have changed over that time period.

 

		5.	The Compliance Officer’s decision on clearance, whether approved or denied, shall be kept confidential.

 

Pre-clearance requests should be submitted by completing one
of the forms attached hereto as Exhibit B and Exhibit C and by following all associated instructions.

 

IX.       Blackout
Periods Applicable to Covered Persons

 

A.               
No Trading During Blackout Periods. No Covered Person may trade or effectuate any other transactions in Company securities
during regular blackout periods or during any special blackout periods designated by the Compliance Officer (except for the limited
exceptions described in Section V.B above). Remember that even during an open trading window, you may not trade in Company securities
if you are in possession of material nonpublic information concerning the Company or its securities.

 

B.                
Regular Blackout Periods Defined. Subject to obtaining trading pre-approval from the Compliance Officer in accordance
with the procedures set forth in Section VIII above, Covered Persons may not trade in Company securities during the period that
ends ten business days prior to the end of the fiscal quarter and continues until the close of trading on the first full business
day after the Company’s public release of quarterly or annual financial results. To provide clarity, the Compliance Officer
will notify Covered Persons, in advance of each quarter end, of the date on which the blackout period begins and ends. Trades made
pursuant to an approved 10b5-1 Trading Plan (see Section X below) are exempted from this restriction.

 

C.               
Special Blackout Periods. From time to time, the Compliance Officer may determine that trading in Company securities
is inappropriate during an otherwise open trading window due to the existence of material nonpublic information. Accordingly, the
Compliance Officer may prohibit trading at any time by announcing a special blackout period. The Compliance Officer will provide
notice of any modification of the trading blackout policy or any additional prohibition on trading during the period when trading
is otherwise permitted under this Policy. The existence of a special blackout period should be considered confidential information
and Covered Persons are prohibited from communicating the existence of a special blackout period to anyone who is not a Covered
Person.

 

D.               
Blackout Periods Required by the Sarbanes-Oxley Act of 2002. In order to comply with certain provisions of the Sarbanes-Oxley
Act of 2002, no director or executive officer of the Company may, directly or indirectly, purchase, sell or otherwise acquire or
transfer any equity security of the Company during any period of time that participants in the Company’s 401(k) plan are
prohibited from trading interests in the Company’s equity securities under such plan. The “blackout period” is
defined for purposes of this rule as any period of more than three consecutive business days during which the ability of 50 percent
or more of the participants or beneficiaries located in the United States under all individual account plans of the Company to
purchase or sell any equity securities of the Company under

 

any such plan is suspended by action of the Company or a fiduciary
of the plan. The Sarbanes-Oxley Act requires the Company to timely notify affected directors and executive officers and the SEC
of any such blackout period. If you are a director or executive officer of the Company, the Compliance Officer will disapprove
any requested transaction involving equity securities of the Company that would occur during a blackout period for participants
in the Company’s 401(k) plan.

 

E.       Hardship
Trading Exceptions. The Compliance Officer may, on a case-by-case basis, authorize trading in Company securities during a trading
blackout period due to financial or other hardship. Any person wanting to rely on this exception must first notify the Compliance
Officer in writing of the circumstance of the hardship and the amount and nature of the proposed trade. Such person will
also be required to certify to the Compliance Officer in writing no earlier than two business days prior to the proposed trade
that he or she is not in possession of material nonpublic information concerning the Company or its securities. Upon authorization
from the Compliance Officer, the person may trade, although such person will be responsible for ensuring that any such trade complies
in all other respects with this Policy.

 

 

 

    	 	14	 

     

    

 

X.       10b5-1
Trading Plans

 

The Compliance Officer must pre-clear any
Rule 10b5-1 trading plan4. A Rule 10b5-1 trading plan is a contract to purchase or sell securities according to a written
instruction or plan established prior to making any transactions. The Rule 10b5-1 trading plan must be adopted in good faith and
without knowledge of material nonpublic information. Covered Persons who wish to enter into a Rule 10b5-1 trading plan must obtain
the prior written approval of the Compliance Officer. Prior written approval is likewise required before a Covered Person may modify,
in any way, an approved Rule 10b5-1 trading plan. Transactions effected under an approved Rule 10b5-1 trading plan will not require
further preclearance at the time of the trade and will not be subject to the trading blackout periods under this Policy.

 

In order to receive pre-clearance, a trading plan must meet
the following parameters:

 

		(1)	No trading plan may be adopted, terminated, amended, revised or otherwise modified except during a Window Period when that
individual is not then in possession of any material nonpublic information.

 

		(2)	No plan participant may engage in extra-plan, corresponding hedging positions with respect to Company stock.

 

		(3)	The effective date of the trading plan must be not less than thirty (30) days following adoption of the trading plan.

 

		(4)	The trading plan may not be modified more than once every six (6) months following the plan’s adoption or any modification
of the plan and such modifications shall not take effect until at least ninety (90) days after adoption of such modification.

 

		(5)	A trading plan may be terminated upon prior written notice. If a trading plan is terminated prior to its stated term and
                                                               a new plan adopted in its place, the new trading plan shall not take effect until ninety (90) days following its adoption.
                                                               Notwithstanding the foregoing, a new trading plan adopted for the sole purpose of selling stock to satisfy the tax
                                                               obligations upon vesting of a restricted stock grant may take effect in less than ninety (90) days following its
                                                               adoption.

 

 

__________

4
A trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, if properly structured, provides an
affirmative defense to a claim that the insider traded on the basis of material nonpublic information.

  

Purchases and sales made pursuant to a Rule
10b5 -1 trading plan must still comply with all other applicable reporting requirements under federal and state securities laws,
including Form 4 filings pursuant to Section 16 of the Securities Exchange Act of 1934.

 

XI.       Instructions
for Pre-clearance for the Purchase or Sale of Acacia Stock or Exercising of

 

Acacia Stock Options 

 

Pre-clearance for Covered Persons is mandatory.
Please request pre-clearance for a transaction by giving a copy of the Advanced Notice for Personal Trading Form for RSAs and RSUs,
attached hereto as Exhibit B, and the Pre-Clearance to Exercise Options Form for stock options, attached hereto as Exhibit
C, to Jennifer Graff.

 

 

 

    	 	15	 

     

    

 

EXHIBIT A

 

CERTIFICATION

 

I hereby certify that:

 

		·	I have read and understand the Company’s Insider Trading Policy Statement of Polices and Procedures Governing Material
Nonpublic Information and the Prevention of Insider Trading. I understand that the Company’s Compliance Officer is available
to answer any questions I have regarding this Insider Trading Policy.

 

		·	Since the effective date of the Insider Trading Policy, or such shorter period of time that I have been a director, officer,
employee or contractor of the Company, I have complied with the Insider Trading Policy.

 

		·	I will continue to comply with the Company’s Insider Trading Policy for as long as I am a director, officer, employee
or contractor of the Company.

 

		·	I understand that failure to comply with the Insider Trading Policy could subject me to disciplinary action or termination
of the business or employment relationship with Acacia.

 

 

	 	 	 
	Signature	 	Date
	 	 	 
	 	 	 
	Printed Name (Please print legibly)	 	 

 

 

 

Exhibit A

 

    	 	 	 

     

    

 

 

EXHIBIT B

 

ADVANCE NOTICE FOR PERSONAL TRADING FORM

 

TO:          Acacia Research Corporation

 

FROM:

 

DATE:

 

RE:          Advance
Notice for Personal Trading

 

I, the undersigned, hereby give advance notice to Acacia Research
Corporation that I intend to ☐ purchase ☐ sell up
to______________ shares of Acacia Research Corporation common stock.

 

	 	☐	These shares are held in my 401(k) plan.
	 	 	 
	 	☐	__________ of these shares were obtained from options that I exercised on , 20___:

 

o           
At $______ per share (the exercise price)

 

o           
Granted on ___________, 20___

I hereby certify as of the date above that:

 

		·	I have previously received and am familiar with the Company’s insider trading policy;

 

		·	I have complied with all procedures established by the Company’s insider trading policy in
connection with the transaction described above; and

 

		·	to my knowledge, I am not in possession of any material nonpublic information about the Company and/or its affiliated companies.

 

I acknowledge that I have ten (10) business days from the date
of approval, or until the window closes, whichever is shorter, in which to complete the trade I have requested.

 

	 	 
	 	Signature:
	 	 
	 	MANAGEMENT APPROVAL
	 	 
	 	 
	 	 
	 	 
	 	Date:___________________
	 	 

 

 

 

    	 	16	 

     

    

 

EXHIBIT C

 

PRE-CLEARANCE TO EXERCISE OPTIONS

 

I, )_____________, hereby notify Acacia Research
Corporation (the “Corporation”) that I elect to purchase____________ shares (the “Exercised Shares”)
of the Corporation’s Common Stock (“Common Stock”) at the option exercise price ofper share (the
“Exercise Price”) pursuant to that certain option granted to me under the Acacia Research Corporation 20__Stock
Incentive Plan on ____________, 20__(the “Option”).

 

Type of Option 

 

	 ___________ Incentive Option (ISO)	__________ Non-Statutory Option (Non-Qual)

 

 

Type of Transaction

 

	____	Cash Exercise (Purchase of the option shares with the intent to hold the shares for sale at a future date). NOTE: If you
choose to do a cash exercise, you may not sell the acquired share without subsequent approval during a period when the trading
window is open. Please refer to the Acacia Insider Trading Policy.

 

	____	Cashless Exercise (Same-day purchase of the option shares and immediate sale of all the shares on the open market.)

 

	____	Sell-to-Cover Exercise (Purchase of the option shares and immediate sale of less than all the shares). NOTE: If you choose
to do a Sell-to-Cover exercise, you may not sell the remaining shares without subsequent approval during a period when the trading
window is open. Please refer to the Acacia Insider Trading policy.

 

Concurrently with the delivery of this Notice of Exercise to
the Corporation, I shall pay, or cause to be paid to the Corporation the Exercise Price for the Exercised Shares in accordance
with the provisions of my agreement with the Corporation (or other documents) evidencing the Option and shall deliver whatever
additional documents may be required by such agreement as a condition for exercise.

 

I hereby certify as of the date above that:

 

		·	I have previously received and am familiar with the Corporation’s Insider Trading Policy;

 

		·	I have complied with all procedures established by the Corporation’s Insider Trading Policy in connection with the transaction
described above; and

 

		·	To my knowledge, I am not in possession of any material nonpublic information about the Corporation and/or its affiliated companies.

 

I acknowledge that I have ten (10) business days from the date
of approval, or until the window closes, whichever is shorter, in which to complete the trade I have requested. I also acknowledge
that I will notify Jennifer Graff by email as soon as I have given my broker any exercise instructions.

 

	 	 
	 	Signature:
	 	 
	MANAGEMENT APPROVAL	
	 	 
	 	 
	 	 
	 	 
	Date: ______________	 
	 	 

 

 

Exhibit C

 

 

 

    	 	 	 

     

    

 

EXHIBIT B

 

SEXUAL HARASSMENT POLICY

 

See attached.

 

 

 

 

 

 

 

 

 

 

 

    	 	17	 

     

    

 

Sexual Harassment Prevention Policy, New York Employees

 

Acacia Research Corporation (the “Company”)
is committed to maintaining a workplace free from sexual harassment. Sexual harassment is a form of workplace discrimination.
All employees are required to work in a manner that prevents sexual harassment in the workplace. This Policy is one component
of the Company’s commitment to a discrimination-free work environment.

 

Sexual harassment is against the law1
and all employees have a legal right to a workplace free from sexual harassment and employees are urged to report sexual
harassment by filing a complaint internally with the Company. Employees can also file a complaint with a government agency or
in court under federal, state or local antidiscrimination laws.

 

Policy:

 

		1.	This
                                         policy applies to all employees in New York, applicants for employment in New York, interns
                                         in New York, whether paid or unpaid, contractors in New York and persons conducting business,
                                         regardless of immigration status, with the Company in New York. In the remainder of this
                                         document, the term “employees” refers to this collective group. The Company
                                         also maintains a separate general harassment policy, entitled “Harassment,
                                         Discrimination and Retaliation Prevention Policy,” prohibiting
                                         all forms of harassment and discrimination based on any characteristic protected by applicable
                                         federal, state or local law, and which applies to all employees of the Company. This
                                         Policy is designed to supplement the Company’s Harassment, Discrimination and Retaliation
                                         Prevention Policy as to the Company’s prohibition on sexual harassment for those
                                         individuals subject to this policy only. To the extent there is any conflict between
                                         this policy and the Company’s Harassment, Discrimination and Retaliation Prevention
                                         Policy, this policy will control over the Company’s Harassment, Discrimination
                                         and Retaliation Prevention Policy as to those individuals subject to this policy.

 

		2.	Sexual harassment will not be tolerated. Any employee
                                         or individual covered by this policy who engages in sexual harassment or retaliation
                                         will be subject to remedial and/or disciplinary action (e.g., counseling, suspension,
                                         termination).

 

		3.	Retaliation
                                         Prohibition: No person covered by this Policy shall
                                         be subject to adverse action because they report an incident of sexual harassment, provides
                                         information, or otherwise assists in any investigation of a sexual harassment complaint.
                                         The Company will not tolerate such retaliation against anyone who, in good faith, reports
                                         or provides information about suspected sexual harassment. Any employee of the Company
                                         who retaliates against anyone involved in a sexual harassment investigation will be subjected
                                         to disciplinary

 

__________

1 While this policy
specifically addresses sexual harassment, harassment because of and discrimination against persons of all protected classes is
prohibited. In New York State, such classes include age, race, creed, color, national origin, sexual orientation, military status,
sex, disability, marital status, domestic violence victim status, gender identity and criminal history. See the Company’s
Harassment, Discrimination and Retaliation Prevention Policy or contact the Human Resources for more information.action, up to
and including termination. All employees, paid or unpaid interns, or non-employees2 working in the workplace who believe
they have been subject to such retaliation should inform a supervisor, manager, or the Company’s Director of Human Resources.
All employees, paid or unpaid interns or non-employees who believe they have been a target of such retaliation may also seek relief
in other available forums, as explained below in the section on Legal Protections.

 

 

    	 	18	 

     

    

 

		4.	Sexual harassment is offensive, is a violation of our policies, is unlawful, and may subject the Company to liability for harm
to targets of sexual harassment. Harassers may also be individually subject to liability. Employees of every level who engage in
sexual harassment, including managers and supervisors who engage in sexual harassment or who allow such behavior to continue, will
be penalized for such misconduct.

 

		5.	The Company will conduct a prompt and thorough investigation that ensures due process for all parties, whenever management
receives a complaint about sexual harassment, or otherwise knows of possible sexual harassment occurring. The Company will keep
the investigation confidential to the extent possible. Effective corrective action will be taken whenever sexual harassment is
found to have occurred. All employees, including managers and supervisors, are required to cooperate with any internal investigation
of sexual harassment.

 

		6.	All employees are encouraged to report any harassment or behaviors that violate this policy. The Company will provide all employees
a complaint form for employees to report harassment and file complaints.

 

		7.	Managers and supervisors are required to report any complaint
                                         that they receive, or any harassment that they observe or become aware of, to the Director
                                         of Human Resources.

 

		8.	This policy applies to all employees, paid or unpaid interns, and non-employees in New York and all must follow and uphold
this policy. This policy must be provided to all New York employees and should be posted prominently in all work locations to the
extent practicable (for example, in a main office, not an offsite work location) and be provided to New York employees upon hiring.

 

What Is “Sexual Harassment”?

 

Sexual harassment is a form of sex discrimination
and is unlawful under federal, state, and (where applicable) local law. Sexual harassment includes harassment on the basis of sex,
sexual orientation, self-identified or perceived sex, gender expression, gender identity and the status of being transgender.

 

__________

2 A non-employee is
someone who is (or is employed by) a contractor, subcontractor, vendor, consultant, or anyone providing services in the workplace.
Protected non-employees include persons commonly referred to as independent contractors, “gig” workers and temporary
workers. Also included are persons providing equipment repair, cleaning services or any other services provided pursuant to a
contract with the employer.

 

 

    	 	19	 

     

    

 

Sexual harassment includes unwelcome conduct
which is either of a sexual nature, or which is directed at an individual because of that individual’s sex when:

 

		·	Such conduct has the purpose or effect of unreasonably interfering
with an individual’s work performance or creating an intimidating, hostile or offensive work environment, even if the reporting
individual is not the intended target of the sexual harassment;

 

		·	Such conduct is made either explicitly or implicitly a term or condition
of employment; or

 

		·	Submission to or rejection of such conduct is used as the basis for
employment decisions affecting an individual’s employment.

 

A sexually harassing hostile work environment
includes, but is not limited to, words, signs, jokes, pranks, intimidation or physical violence which are of a sexual nature, or
which are directed at an individual because of that individual’s sex. Sexual harassment also consists of any unwanted verbal
or physical advances, sexually explicit derogatory statements or sexually discriminatory remarks made by someone which are offensive
or objectionable to the

 

recipient, which cause the recipient discomfort or humiliation,
which interfere with the recipient’s job performance.

 

Sexual harassment also occurs when a person
in authority tries to trade job benefits for sexual favors. This can include hiring, promotion, continued employment or any other
terms, conditions or privileges of employment. This is also called “quid pro quo” harassment.

 

Any employee who feels harassed should complain
so that any violation of this policy can be corrected promptly. Any harassing conduct, even a single incident, can be addressed
under this policy.

 

Examples of sexual harassment

 

The following describes some of the types
of acts that may be unlawful sexual harassment and that are strictly prohibited:

 

		·	Physical acts of a sexual nature, such as:

 

		o	Touching, pinching, patting, kissing, hugging, grabbing, brushing against another employee’s body or poking another employee’s
body;

 

		o	Rape, sexual battery, molestation or attempts to commit these assaults.

 

		·	Unwanted sexual advances or propositions, such as:

 

		o	Requests for sexual favors accompanied by implied or overt threats concerning the target’s job performance evaluation,
a promotion or other job benefits or detriments;

 

		o	Subtle or obvious pressure for unwelcome sexual activities.

 

		·	Sexually oriented gestures, noises, remarks or jokes, or comments
about a person’s

 

sexuality or sexual experience, which create a hostile work
environment.

 

		·	Sex stereotyping occurs when conduct or personality traits are considered
inappropriate simply because they may not conform to other people's ideas or perceptions about how individuals of a particular
sex should act or look.

 

		·	Sexual or discriminatory displays or publications anywhere in the
workplace, such as:

 

 

 

    	 	20	 

     

    

 

		o	Displaying pictures, posters, calendars, graffiti, objects, promotional material, reading materials or other materials that
are sexually demeaning or

 

pornographic. This includes such sexual displays on workplace
computers or cell phones and sharing such displays while in the workplace.

 

		·	Hostile actions taken against an individual because of that individual’s
sex, sexual orientation, gender identity and the status of being transgender, such as:

 

		o	Interfering with, destroying or damaging a person’s workstation, tools or equipment, or otherwise interfering with the
individual’s ability to perform the job;

 

		o	Sabotaging an individual’s work;

 

		o	Bullying, yelling, name-calling.

 

Who can be a target of sexual harassment? 

 

Sexual harassment can occur between any
individuals, regardless of their sex or gender. New York Law protects employees, paid or unpaid interns, and non-employees, including
independent contractors, and those employed by companies contracting to provide services in the workplace.

 

Harassers can be a superior, a subordinate,
a coworker or anyone in the workplace including an independent contractor, contract worker, vendor, client, customer or visitor.

 

Where can sexual harassment occur?

 

Unlawful sexual harassment is not limited
to the physical workplace itself. It can occur while employees are traveling for business or at employer sponsored events or parties.
Calls, texts, emails, and social media usage by employees can constitute unlawful workplace harassment, even if they occur away
from the workplace premises, on personal devices or during non-work hours.

 

Retaliation

 

Unlawful retaliation can be any action that
could discourage a worker from coming forward to make or support a sexual harassment claim. Adverse action need not be job-related
or occur in the workplace to constitute unlawful retaliation (e.g., threats of physical violence outside of work hours).

 

Such retaliation is unlawful under federal,
state, and (where applicable) local law. The New York State Human Rights Law protects any individual who has engaged in “protected
activity.” Protected activity occurs when a person has:

 

		·	made a complaint of sexual harassment, either internally or with any
anti-discrimination agency;

 

		·	testified or assisted in a proceeding
involving sexual harassment under the Human Rights Law or other anti-discrimination law;

 

		·	opposed sexual harassment by making a
verbal or informal complaint to management, or by simply informing a supervisor or manager of harassment;

 

		·	reported that another employee has been
sexually harassed; or

 

 

 

    	 	21	 

     

    

 

		·	encouraged a fellow employee to report
harassment.

 

Even if the alleged harassment does not
turn out to rise to the level of a violation of law, the individual is protected from retaliation if the person had a good faith
belief that the practices were unlawful. However, the retaliation provision is not intended to protect persons making intentionally
false charges of harassment.

 

Reporting Sexual Harassment

 

Preventing sexual harassment is everyone’s
responsibility. The Company cannot prevent or remedy sexual harassment unless it knows about it. Any employee, paid or unpaid
intern or non-employee who has been subjected to behavior that may constitute sexual harassment is encouraged to report such behavior
to a supervisor, manager or the Director of Human Resources. Anyone who witnesses or becomes aware of potential instances of sexual
harassment should report such behavior to a supervisor, manager or the Director of Human Resources.

 

Reports of sexual harassment
may be made verbally or in writing. A form for submission of a written complaint is attached to this Policy, and all employees
are encouraged to use this complaint form. Employees who are reporting sexual harassment on behalf of other employees should use
the complaint form and note that it is on another employee’s behalf.

 

Employees, paid or
unpaid interns or non-employees who believe they have been a target of sexual harassment may also seek assistance in other available
forums, as explained below in the section on Legal Protections.

 

Supervisory Responsibilities

 

All supervisors and managers who receive
a complaint or information about suspected sexual harassment, observe what may be sexually harassing behavior or for any reason
suspect that

 

sexual harassment is occurring, are required to report such
suspected sexual harassment to the Director of Human Resources.

 

In addition to being subject to discipline
if they engaged in sexually harassing conduct themselves, supervisors and managers will be subject to discipline for failing to
report suspected sexual harassment or otherwise knowingly allowing sexual harassment to continue.

 

Supervisors and managers will also be subject to discipline
for engaging in any retaliation.

 

Complaint and Investigation of Sexual
Harassment

 

All complaints or information about
sexual harassment will be investigated, whether that information was reported in verbal or written form. Investigations will be
conducted in a timely manner, and will be confidential to the extent possible.

 

An investigation of any complaint, information
or knowledge of suspected sexual harassment will be prompt and thorough, commenced immediately and completed as soon as possible.
The investigation will be kept confidential to the extent possible. All persons involved, including complainants, witnesses and
alleged harassers will be accorded due process, as outlined below, to protect their rights to a fair and impartial investigation.

 

Any employee may be required to cooperate
as needed in an investigation of suspected sexual harassment. The Company will not tolerate retaliation against employees who file
complaints, support another’s complaint or participate in an investigation regarding a violation of this policy.

 

 

 

    	 	22	 

     

    

 

While the process may vary from case to
case, investigations should be done in accordance with the following steps:

 

		·	Upon receipt of a complaint, the Director of Human Resources or their
designee will conduct an immediate review of the allegations, and take any interim actions (e.g., instructing the respondent to
refrain from communications with the complainant), as appropriate. If the complaint is verbal, the Director of Human Resources
will encourage the individual to complete the “Complaint Form” in writing. If he or she refuses, the Director of Human
Resources will prepare a Complaint Form based on the verbal reporting.

 

		·	If documents, emails or phone records are relevant to the investigation,
take steps to obtain and preserve them.

 

		·	Request and review all relevant documents, including all electronic
communications.

 

		·	Interview all parties involved, including any relevant witnesses.

 

		·	Create a written documentation of the investigation (such as a letter,
memo or email), which contains the following:

 

		o	A list of all documents reviewed, along with a detailed summary of relevant documents;

 

		o	A list of names of those interviewed, along with a detailed summary of their statements;

 

		o	A timeline of events;

 

		o	A summary of prior relevant incidents, reported or unreported; and

 

		o	The basis for the decision and final resolution of the complaint, together with any corrective action(s).

 

		·	Keep the written documentation and associated documents in a secure
and confidential location.

 

		·	Promptly notify the individual who reported and the individual(s)
about whom the complaint was made of the final determination and implement any corrective actions identified in the written document.

 

		·	Inform the individual who reported of the right to file a complaint
or charge externally as outlined in the next section.

 

Legal Protections And External Remedies

 

Sexual harassment is not only prohibited
by the Company, but is also prohibited by state, federal, and, where applicable, local law.

 

Aside from the internal process at the Company,
employees may also choose to pursue legal remedies with the following governmental entities. While a private attorney is not required
to file a complaint with a governmental agency, you may seek the legal advice of an attorney.

 

In addition to those outlined below, employees
in certain industries may have additional legal protections.

 

New York State Human Rights Law (HRL)

 

The Human Rights Law (HRL), codified as
N.Y. Executive Law, art. 15, § 290 et seq., applies to all employers in New York State with regard to sexual harassment, and
protects employees, paid or unpaid interns and non-employees, regardless of immigration status. A complaint alleging violation
of the Human Rights Law may be filed either with the Division of Human Rights (DHR) or in New York State Supreme Court.

 

Complaints with DHR may be filed any time
within one year of the harassment. If an individual did not file at DHR, they can sue directly in state court under the
HRL, within three years of the alleged sexual harassment. An individual may not file with DHR if they have already filed
a HRL complaint in state court.

 

 

 

    	 	23	 

     

    

 

Complaining internally to the Company, including
the Director of Human Resources, does not extend your time to file with DHR or in court. The one year or three years is counted
from date of the most recent incident of harassment.

 

You do not need an attorney to file a complaint
with DHR, and there is no cost to file with DHR.

 

DHR will investigate your complaint and
determine whether there is probable cause to believe that sexual harassment has occurred. Probable cause cases are forwarded to
a public hearing before an administrative law judge. If sexual harassment is found after a hearing, DHR has the power to award
relief, which varies but may include requiring your employer to take action to stop the harassment, or redress the damage caused,
including paying of monetary damages, attorney’s fees and civil fines.

 

DHR’s main office contact information
is: NYS Division of Human Rights, One Fordham Plaza, Fourth Floor, Bronx, New York 10458. You may call (718) 741-8400 or visit:
www.dhr.ny.gov,

 

Contact DHR at (888) 392-3644 or visit dhr.ny.gov/complaint
for more information about filing a complaint. The website has a complaint form that can be downloaded, filled out, notarized and
mailed to DHR. The website also contains contact information for DHR’s regional offices across New York State.

 

Civil Rights Act of 1964

 

The United States Equal Employment Opportunity
Commission (EEOC) enforces federal antidiscrimination laws, including Title VII of the 1964 federal Civil Rights Act (codified
as 42 U.S.C. § 2000e et seq.). An individual can file a complaint with the EEOC anytime within 300 days from the harassment.
There is no cost to file a complaint with the EEOC. The EEOC will investigate the complaint, and determine whether there is reasonable
cause to believe that discrimination has occurred, at which point the EEOC will issue a Right to Sue letter permitting the individual
to file a complaint in federal court.

 

The EEOC does not hold hearings or award
relief, but may take other action including pursuing cases in federal court on behalf of complaining parties. Federal courts may
award remedies if discrimination is found to have occurred. In general, private employers must have at least 15 employees to come
within the jurisdiction of the EEOC.

 

An employee alleging discrimination at work
can file a “Charge of Discrimination.” The EEOC has district, area, and field offices where complaints can be filed.
Contact the EEOC by calling 1-800-669- 4000 (TTY: 1-800-669-6820), visiting their website at www.eeoc.gov or via email at info@eeoc.gov,

 

If an individual filed an administrative
complaint with DHR, DHR will file the complaint with the EEOC to preserve the right to proceed in federal court.

 

Local Protections

 

Many localities, including New York City,
enforce laws protecting individuals from sexual harassment and discrimination. An individual should contact the county, city or
town in which they live to find out if such a law exists. For example, employees who work in New York City may file complaints
of sexual harassment with the New York City Commission on Human Rights. Contact their main office at Law Enforcement Bureau of
the NYC Commission on Human Rights, 40 Rector Street, 10th Floor, New York, New York; call 311 or (212) 306-7450; or visit www.nyc.gov/html/cchr/html/home/home.shtml.

 

Contact the Local Police Department

 

If the harassment involves unwanted physical
touching, coerced physical confinement or coerced sex acts, the conduct may constitute a crime. Contact the local police department.

 

 

 

    	 	24	 

     

    

 

HARASSMENT, DISCRIMINATION AND RETALIATION PREVENTION POLICY

 

Acacia Research Corporation (the “Company”)
is committed to providing a workplace free of sexual harassment and discrimination (which includes harassment or discrimination
based on pregnancy, childbirth, breastfeeding and related medical conditions) as well as unlawful harassment and discrimination
based on such factors as race, color, religious creed (including religious dress and grooming practices), creed, family status,
national origin (including language use restrictions), ancestry, age for individuals over forty years of age, physical disability
(including HIV/AIDS), mental disability, medical condition (including cancer), genetic information, genetic condition, genetic
characteristics, actual or perceived marital status, registered domestic partner status, sexual orientation, gender, gender identity,
gender expression, alienage or citizenship status, domestic violence victim status, consumer credit history, caregiver status,
unemployment status, arrest records and conviction status under certain circumstances to the extent required by applicable law,
sexual and reproductive health decisions, military and veteran status, denial or use of family and medical care leave, and any
other factor made unlawful by federal, state, or local law. Discrimination and harassment are also prohibited on the basis of a
perception that a person has any of the above characteristics, or that the person is associated with a person who has, or is perceived
to have, any of the above characteristics. The Company strongly disapproves of and will not tolerate any form or unlawful harassment
or discrimination, including against employees or applicants by managers, supervisors, or co-workers, as well as by third parties
in the workplace or with whom the employee comes into contact in connection with their employment.

 

This policy applies to all Company employees,
paid or unpaid interns, volunteers, and any other persons providing services to the Company pursuant to a contract. The Company
also maintains a separate policy prohibiting sexual harassment, entitled “Sexual Harassment Prevention Policy, New York
Employees,” that supplements this policy and that applies only to all employees, paid or unpaid interns, volunteers,
contractors and any other persons providing services to or conducting business with the Company in New York. To the extent there
is any conflict between this policy and the Company’s Sexual Harassment Policy, New York Employees, the Sexual Harassment
Policy, New York Employees will control over this policy as to those individuals subject to that policy.

 

Harassment includes verbal, physical, and
visual conduct, as well as communication through electronic media of any type, that creates an intimidating, offensive or hostile
working environment or interferes with work performance. Such conduct constitutes harassment when (1) submission to the conduct
is made either an explicit or implicit condition of employment; (2) submission to or rejection of the conduct is used as the basis
for an employment decision; or (3) the harassment interferes with an employee’s work performance or creates an intimidating,
hostile or offensive work environment. Harassing conduct can take many forms and includes, but is not limited to, slurs, jokes,
statements, gestures, pictures, or cartoons regarding an employee’s sex, race, color, national origin, religion, age, physical
disability, medical condition, ancestry, marital status, sexual orientation, gender, gender identity, veteran status, or other
protected status.

 

Sexually harassing conduct in particular
includes all of these prohibited actions as well as other unwelcome conduct such as requests for sexual favors, unwelcome sexual
advances, verbal conduct of a sexual nature (like name calling, suggestive comments, or lewd talk) or physical

 

conduct (including assault, unwanted touching, intentionally
blocking normal movement or interfering with work because of sex or any other protected basis). An employee who unlawfully harasses
a co-worker may be personally liable for the harassment.

 

If you believe you or a co-worker has been
subjected to any form of unlawful discrimination or harassment, including sexual harassment, you should immediately contact your
supervisor or report the issue directly to the Director of Human Resources, either orally or in writing. A manager or supervisor
who learns of any misconduct which may be in violation of this policy or learns of an employee’s complaint or concern about
a possible violation of this policy must immediately report the issue to the Company’s Director of Human Resources.

 

Upon receipt of any complaint, the Company
will immediately undertake a prompt, impartial, and thorough investigation conducted by qualified personnel, preserving confidentiality
to the extent possible. All complaints under this policy will receive a timely response, documentation and tracking of progress,
and timely closure. The investigation will provide all parties appropriate due process and reach reasonable conclusions based on
the evidence collected, as well as determine appropriate options for remedial action to resolve the situation. If at the end of
the investigation misconduct is found, the Company will take appropriate remedial measures. If you have a complaint being investigated
under this policy, you can find out about the progress of the investigation by contacting the Director of Human Resources.

 

 

 

    	 	25	 

     

    

 

Retaliation against Company employees or
any other person for the good faith reporting of possible acts or incidents of discrimination or harassment, as well as for participating
in any workplace investigation, will not be tolerated. If you believe you or a co-worker has been subjected to any form of unlawful
retaliation, you should immediately contact your supervisor or the Director of Human Resources, either orally or in writing. Upon
receipt of a retaliation complaint, the Company will undertake an investigation consistent with the provisions of this policy.
Company employees shown to have engaged in such retaliation will be disciplined, up to and including discharge.

 

Sexual harassment and retaliation for opposing
sexual harassment or participating in investigations of sexual harassment are illegal. In addition to notifying the Company about
discrimination, harassment or retaliation complaints, affected employees may also direct their complaints to the federal, state
and/or local agencies with responsibility for enforcing laws related to harassment, discrimination or retaliation, such as the
California Department of Fair Employment and Housing (DFEH), New York State Division of Human Rights, or any of the local offices
of the U.S. Equal Employment Opportunity Commission (EEOC).

 

The U.S. Equal Employment Opportunity Commission,
California Department of Fair Employment and Housing, New York State Division of Human Rights and other agencies are authorized
to accept and investigate complaints of employment discrimination, harassment and/or retaliation, and to mediate settlements. Certain
agencies, such as the California Fair Employment and Housing Commission (FEHC), have authority to issue accusations against employers,
conduct formal hearings, and award reinstatement, back pay, damages, and other affirmative relief. State and federal law also prohibit
retaliation against employees because they have filed a complaint with the EEOC, New York State Division of Human Rights, DFEH
or other state agencies, participated in an

 

investigation, proceeding, or hearing with such agencies, or
opposed any practice made unlawful by applicable state or federal law.

 

The deadline for filing complaints with
the DFEH or New York State Division of Human Rights is one (1) year from the date of the alleged unlawful conduct. You can contact
the nearest DFEH office or the FEHC at the locations listed in the Company’s DFEH poster or by checking the state government
listings online or in the local telephone directory. The New York State Division of Human Rights main office contact information
is: NYS Division of Human Rights, One Fordman Plaza, Fourth Floor, Bronx, New York 10458, (718) 741-8400, www.dhr.ny.gov,

 

Additional information regarding governmental
agencies responsible for accepting complaints and addressing issues related to harassment, discrimination or retaliation for Company
employees in New York is included in the Company’s Sexual Harassment Prevention Policy, New York Employees,

 

 

 

 

 

 

 

 

 

    	 	26	 

     

    

 

EXHIBIT C

 

EXECUTIVE OFFICER STOCK OWNERSHIP GUIDELINES

 

See attached.

 

 

 

 

 

 

 

 

 

 

 

    	 	27EX-4.6

 Exhibit 4.6 

REGISTRATION RIGHTS AGREEMENT 

This Registration Rights Agreement (the “Agreement”) is made and entered into as of June 4, 2020 by and among Molecular
Templates, Inc., a Delaware corporation (the “Company”), and each Selling Stockholder set forth on the signature pages hereto (each, a “Selling Stockholder” and collectively, the “Selling
Stockholders”). The Company and the Selling Stockholders may each be referred to herein individually as a “Party” and collectively as the “Parties.” 

WHEREAS, each of the Selling Stockholders currently holds shares of capital stock of the Company that are not currently registered for resale
with the Securities and Exchange Commission (the “SEC”); and 
 WHEREAS, the board of directors of the Company has
determined that it is desirable and in the best interests of the Company to grant resale registration rights to the Selling Stockholders as set forth in this Agreement. 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as
follows: 
 1. Registration. 

(a) Registration Statement. 

(i) Resale Registration Statement. The Company shall promptly file with the SEC, to include (by way of filing, amendment or
otherwise) the securities held by the Selling Stockholders as set forth on Annex 1 hereto (the “Registrable Securities”) on a registration statement on Form S-3 so as to cover the resale of
the Registrable Securities (the “Registration Statement”). The Registration Statement (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to the Selling
Stockholders and their counsel, if applicable, prior to its filing or other submission. 
 (ii) Alternative Form of Registration Statement.
In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another
appropriate form reasonably acceptable to the holders of a majority of the Registrable Securities then held by Selling Stockholders (the “Required Holders”) and (ii) undertake to register the Registrable Securities on Form S-3 promptly after such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the SEC. 

(iii) Expenses. The Company will pay all reasonable expenses associated with effecting the registration of the Registrable
Securities pursuant to, and otherwise complying with its obligations under, this Section 1, including filing and printing fees, the Company’s counsel and accounting fees and expenses, costs associated with clearing the Registrable
Securities for sale under applicable state securities laws and listing fees, but excluding discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar securities industry professionals with respect to the Registrable
Securities being sold. The Selling Stockholders shall bear their own expenses, including with respect to any counsel to the Selling Stockholders, if applicable. 

(b) Effectiveness. 

(i) The Company shall use commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after
filing, and shall notify the Selling Stockholders by e-mail after the Registration Statement is declared effective and shall provide the Selling Stockholders with copies of any related prospectus to be
used in connection with the sale or other disposition of the securities covered thereby. 

 (ii) The Company may suspend the use of any prospectus included in the Registration
Statement contemplated by this Section in the event that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material non-public information
concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company or (B) amend or supplement the Registration Statement or the related prospectus so that such
Registration Statement or prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the prospectus in light of the
circumstances under which they were made, not misleading (a “Delay”); provided, that the Company shall promptly (a) notify each Selling Stockholder in writing of the commencement of such Delay, but shall not
(without the prior written consent of a Selling Stockholder) disclose to such Selling Stockholder any material non-public information giving rise to such Delay and (b) advise the Selling
Stockholders in writing to cease all sales under the Registration Statement until the end of such Delay. 
 (c) Rule 415; Cutback. If
at any time the SEC informs the Company that all of the Registrable Securities cannot, based on the provisions of Rule 415 under the Securities Act, be registered for resale as a secondary offering on a single registration statement, or requires any
Selling Stockholder to be named as an “underwriter,” the Company shall use its commercially reasonable efforts to persuade the SEC that the offering contemplated by the Registration Statement is a valid secondary offering and not an
offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Selling Stockholders is an “underwriter.” In the event that, despite the Company’s commercially reasonable efforts and compliance with the
terms of this Section 2(c), the SEC refuses to alter its position, the Company shall (i) remove from the Registration Statement such portion of the Registrable Securities (the “Cut Back Shares”) and/or (ii) agree to such
restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure the Company’s compliance with the requirements of Rule 415 (collectively, the “SEC Restrictions”); provided,
however, that the Company shall not agree to name any Selling Stockholder as an “underwriter” in such Registration Statement without the prior written consent of such Selling Stockholder. Any
cut-back imposed on the Selling Stockholders pursuant to this Section 2(c) shall be allocated among the Selling Stockholders on a pro rata basis, in each case subject to a determination by the SEC that
certain Selling Stockholders must be reduced first based on the number of Registrable Securities held by such Selling Stockholders. For the avoidance of doubt, for purposes of this Section 2(c), the term “commercially reasonable
efforts” shall not require the Company to institute or maintain any action, suit or proceeding against the SEC or any member of the Staff of the SEC. In the event the Company amends the Registration Statement or files a new registration
statement, as the case may be, to remove the Cut Back Shares, the Company will use its commercially reasonable efforts to file with the SEC, as promptly as allowed by SEC, one or more registration statements on Form
S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the initial Registration Statement, as amended, or the new registration statement
(and any such new registration statement shall be deemed a “Registration Statement” hereunder). 
 (d) Notwithstanding
anything in this Agreement to the contrary, the Company may, by written notice to the Selling Stockholders, suspend sales under the Registration Statement after the effective date thereof and/or require that the Selling Stockholders immediately
cease the sale of any Registrable Securities, pursuant thereto if the Company is engaged in a material merger, acquisition or sale or any other pending development that the Company believes may be material. Upon receipt of such notice, each Selling
Stockholder shall immediately discontinue any sales of Registrable Securities pursuant to such registration until such Selling Stockholder is advised in writing by the Company that the current prospectus or amended prospectus, as applicable, may be
used. Immediately after the end of any suspension period under this Section 2(c), the Company shall take all necessary actions (including filing any required supplemental prospectus) to restore the effectiveness of the Registration
Statement and the ability of the Selling Stockholders to publicly resell their Registrable Securities pursuant to such effective Registration Statement. 

2. Company Obligations. In accordance with Section 1, the Company will use commercially reasonable efforts to
effect the registration of the Registrable Securities in accordance with the terms hereof, and pursuant thereto the Company will: 
 (a) use
commercially reasonable efforts to cause such Registration Statement to become effective pursuant to the terms of Section 1 hereof and prepare and file with the SEC such amendments and post-effective amendments to the
Registration Statement and the prospectus as may be necessary to keep the Registration Statement effective for a period that will terminate upon the earlier of (i) the date on which all Registrable Securities covered by such Registration
Statement as amended from time to time, have been sold, (ii) the third anniversary of 

 
the effectiveness of the Registration Statement, or (iii) the date as of which the Investors may sell all of the Registrable Securities covered by such Registration Statement without
restriction pursuant to Rule 144 (or any successor thereto) promulgated under the Securities Act , and to comply with the provisions of the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act
of 1934, as amended (the “Exchange Act”) with respect to the distribution of all of the Registrable Securities covered thereby;; 

(b) furnish to the Selling Stockholders and their legal counsel, if applicable, (i) promptly after the same is prepared and publicly
distributed, filed with the SEC, or received by the Company one (1) copy of the Registration Statement and any amendment thereto, each preliminary prospectus and prospectus and each amendment or supplement thereto, and each letter written by or
on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to the Registration Statement (other than any portion thereof which contains information for
which the Company has sought confidential treatment), and (ii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as each Selling Stockholder may
reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Selling Stockholder that are covered by the Registration Statement; 

(c) immediately notify the Selling Stockholders upon discovery that, or upon the happening of any event as a result of which, the prospectus
includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and promptly prepare, file with
the SEC and furnish to such holder a supplement to or an amendment of such prospectus as may be necessary so that such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading in light of the circumstances then existing; 
 (d) in the event of any
underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the underwriter(s) of such offering; 

(e) promptly make available for inspection by the Selling Stockholders, any underwriter(s) participating in any disposition pursuant to
such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the Selling Stockholders, all financial and other records, pertinent corporate documents, and properties of the Company, and
cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify
the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; and 
 (f)
otherwise comply with all applicable rules and regulations of the SEC under the Securities Act and the Exchange Act. 

3. Obligations of the Selling Stockholders. 

(a) Each Selling Stockholder shall furnish in writing to the Company such information regarding itself, the Registrable Securities held by it
and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the
Company may reasonably request. At least three (3) business days prior to the first anticipated filing date of the Registration Statement, the Company shall notify each Selling Stockholder of the information the Company requires from such
Selling Stockholder. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities of a particular Selling Stockholder that (i) such
Selling Stockholder furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the
effectiveness of the registration of such Registrable Securities, and (ii) the Selling Stockholder execute such documents in connection with such registration as the Company may reasonably request. 

(b) Each Selling Stockholder agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and
filing of the Registration Statement hereunder. 

 (c) Each Selling Stockholder agrees that, upon receipt of any notice from the Company of
either (i) the commencement of an Delay pursuant to Section 1(b)(ii) or (ii) to the happening of an event pursuant to Section 2(c) hereof, such Selling Stockholder will immediately
discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities, until the Selling Stockholder is advised by the Company that such dispositions may again be made. 

(d) Each Selling Stockholder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as
applicable to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement. 

4. Indemnification. 

(a) Indemnification by the Company. In the event that any Registrable Securities are included in the Registration Statement
pursuant to this Agreement, the Company will indemnify and hold harmless each Selling Stockholder whose Registrable Securities are included in the Registration Statement and its officers, directors, members, employees and agents, successors and
assigns, and each other person, if any, who controls such Selling Stockholder within the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which they may become subject under the Securities Act
or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement or omission or alleged omission of any material fact
contained in the Registration Statement, any preliminary prospectus (if used prior to the effective date of such Registration Statement) or final prospectus, or any amendment or supplement thereof; (ii) any violation by the Company or its
agents of any rule or regulation promulgated under the Securities Act applicable to the Company or its agents and relating to action or inaction required of the Company in connection with such registration; or (iii) any failure to register or
qualify the Registrable Securities included in the Registration Statement in any state where the Company or its agents has affirmatively undertaken or agreed in writing that the Company will undertake such registration or qualification on a Selling
Stockholder’s behalf and will reimburse such Selling Stockholder, and each such officer, director or member and each such controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case if and to the extent that any such loss, claim, damage or liability arises out of or is
based solely upon (w) an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information pertaining to such Selling Stockholder and furnished in writing by such Selling Stockholder or any such
controlling person specifically for use in such Registration Statement or prospectus, (x) the use by a Selling Stockholder of an outdated or defective prospectus after the Company has validly notified such Selling Stockholder in writing that
the prospectus is outdated or defective, (y) a Selling Stockholder’s (or any other indemnified Person’s) failure to send or give a copy of the prospectus or supplement (as then amended or supplemented), if required (and not exempted)
to the Persons asserting an untrue statement or omission or alleged untrue statement or omission at or prior to the written confirmation of the sale of Registrable Securities if such statement or omission was corrected in such prospectus or
supplement, or (z) amounts paid in settlement of any loss, claim, damage or liability if such settlement is effected without the prior written consent of the Company unless, in accordance with Section 6(c) below, such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of the proceeding. 

(b) Indemnification by the Selling Stockholders. Each Selling Stockholder agrees, severally but not jointly, to indemnify and hold
harmless, to the fullest extent permitted by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning of the Securities Act), to the same extent and in the same manner as is set
forth in Section 4(a), against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from any untrue statement of a material fact or any omission of a material fact required to be stated in
the Registration Statement or prospectus or preliminary prospectus or amendment or supplement thereto or necessary to make the statements therein not misleading, to the extent, but only to the extent that such untrue statement or omission is
contained in any information pertaining to such Selling Stockholder and furnished in writing by such Selling Stockholder to the Company specifically for inclusion in the Registration Statement or prospectus or amendment or supplement thereto. In no
event shall the liability of a Selling Stockholder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Selling Stockholder in connection with any claim relating to
this Section 4 and the amount of any damages such Selling Stockholder has otherwise been required to pay by reason of such untrue statement or omission) received by such Selling Stockholder upon the sale of the
Registrable Securities included in the Registration Statement giving rise to such indemnification obligation. 
  

 (c) Conduct of Indemnification Proceedings. Any person entitled to
indemnification hereunder shall (i) give prompt notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such claim with counsel
reasonably satisfactory to the indemnified party; provided, that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses
of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed to pay such fees or expenses or (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel
reasonably satisfactory to such person or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in
which case, if the person notifies the indemnifying party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on
behalf of such person); and provided, further, that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such
failure to give notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be
liable for fees or expenses of more than one separate firm of attorneys at any time for all such indemnified parties. 
 No indemnifying
party will, except with the consent of the indemnified party, consent to entry of any judgment or enter into any settlement unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the
subject matter of such proceeding and such settlement does not include any non-monetary limitation on the actions of any indemnified party or any of its affiliates or any admission of fault or
liability on behalf of any such indemnified party. 
 Subject to the terms of this Agreement, all fees and expenses of the indemnified party
(including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such proceeding in a manner not inconsistent with this Section 4) shall be paid to the indemnified party, as
incurred, within twenty (20) business days of written notice thereof to the indemnifying party; provided, that the indemnified party shall promptly reimburse the indemnifying party for that portion of such fees and expenses
applicable to such actions for which such indemnified party is finally judicially determined to not be entitled to indemnification hereunder). 

(d) Contribution. If for any reason the indemnification provided for in the preceding paragraphs (a) and (b) is
unavailable to an indemnified party or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such loss, claim,
damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations. No person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation. In no event shall the contribution obligation of a holder of Registrable Securities be
greater in amount than the dollar amount of the proceeds (net of all expenses paid by such holder in connection with any claim relating to this Section 6 and the amount of any damages such holder has otherwise been required to
pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation. 

(e) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations
of the Company and Selling Stockholders under this Subsection 4 shall survive the completion of any offering of Registrable Securities in a registration under this Agreement, and otherwise shall survive the termination of this Agreement. 

 5. Miscellaneous. 

(a) Amendments and Waivers. This Agreement may be amended, and any term hereof may be waived, only by a writing signed by the
Company and the Required Holders. 
 (b) Notices. Any notice or other communication required or permitted to be delivered to any
party under this Agreement will be in writing and will be deemed properly delivered, given and received: (a) if sent on a business day by email before 11:59 p.m. (recipient’s time), when transmitted and (b) if sent by email on a day
other than a business day, or if sent by email after 11:59 p.m. (recipient’s time), on the business day following the date when transmitted, in each case to the address set forth beneath the name of such party on the signature pages attached
hereto. 
 (c) Assignments and Transfers by Selling Stockholders. The provisions of this Agreement shall be binding upon and
inure to the benefit of the Selling Stockholders. A Selling Stockholder may transfer or assign, in whole or from time to time in part, to one or more persons its rights hereunder in connection with the transfer of Registrable Securities by such
Selling Stockholder to such person, provided that such Selling Stockholder complies with all laws applicable thereto and provides written notice of assignment to the Company promptly after such assignment is effected. 

(d) Benefits of the Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the
respective permitted successors and assigns of the Parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the Parties or their respective successors and assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 (e) Counterparts; Faxes.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may also be executed via facsimile, which shall be deemed
an original. 
 (f) Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are
not to be considered in construing or interpreting this Agreement. 
 (g) Severability. Any provision of this Agreement that is
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as if it were written
so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent
permitted by applicable law, the Parties hereby waive any provision of law which renders any provisions hereof prohibited or unenforceable in any respect. 

(h) Further Assurances. The Parties shall execute and deliver all such further instruments and documents and take all such other
actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained. 

(i) Entire Agreement. This Agreement is intended by the Parties as a final expression of their agreement and intended to be a
complete and exclusive statement of the agreement and understanding of the Parties in respect of the subject matter contained herein. This Agreement supersedes all prior agreements and understandings among the Parties with respect to such subject
matter. 
 (j) Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed
in accordance with, the internal laws of the State of Delaware without regard to the choice of law principles thereof. Each of the Parties irrevocably submits to the exclusive jurisdiction of the courts of the Delaware Court of Chancery and any
state appellate court therefrom within the State of Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular mater, any
state or federal court within the State of Delaware) for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such
suit, action or proceeding may be served on 

 
each Party anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the Parties irrevocably consents to the jurisdiction of any such
court in any such suit, action or proceeding and to the laying of venue in such court. Each Party irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim
that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT
COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER. 
 [Signature page follows] 

 IN WITNESS WHEREOF, the Parties have executed this Registration Rights Agreement as of the
date first above written. 
  

							
	The Company:	 		 	MOLECULAR TEMPLATES, INC.
				
		 		 	By:	 	 /s/ Eric E. Poma

		 		 	Name:	 	Eric E. Poma
		 		 	Its:	 	 Chief Executive Officer
  

Email Address:

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have executed this Registration Rights Agreement as of the
date first above written. 
  

							
	Selling Stockholder:	 		 	SANTÉ HEALTH VENTURES ANNEX FUND, L.P.
				
		 		 	By:	 	SHV Annex Services, LP
		 		 	Its:	 	General Partner
				
		 		 	By:	 	SHV Management Services, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Kevin Lalande

		 		 	Name:	 	Kevin Lalande
		 		 	Title:	 	Managing Member
			
		 		 	Email Address:
			
	Selling Stockholder:	 		 	SANTÉ HEALTH VENTURES I, L.P.
				
		 		 	By:	 	SHV Management Services, LP
		 		 	Its:	 	General Partner
				
		 		 	By:	 	SHV Management Services, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Kevin Lalande

		 		 	Name:	 	Kevin Lalande
		 		 	Title:	 	Managing Member
			
		 		 	Email Address:
			
	Selling Stockholder:	 		 	SHV MANAGEMENT SERVICES, LP
				
		 		 	By:	 	SHV Management Services, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Kevin Lalande

		 		 	Name:	 	Kevin Lalande
		 		 	Title:	 	Managing Member
			
		 		 	Email Address:

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have executed this Registration Rights Agreement as of the
date first above written. 
  

							
	Selling Stockholder:	 		 	LONGITUDE VENTURE PARTNERS III, L.P.
				
		 		 	By:	 	Longitude Capital Partners, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Patrick Enright

		 		 	Name:	 	Patrick Enright
		 		 	Its:	 	Managing Director
			
		 		 	Email Address:

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have executed this Registration Rights Agreement as of the
date first above written. 
  

							
	Selling Stockholder:	 		 	CDK ASSOCIATES L.L.C.
				
		 		 	 By:
 Its:
	 	 Caxton Corporation
 Manager

				
		 		 	By:	 	 /s/ Karen Cross

		 		 	Name:	 	Karen Cross
		 		 	Its:	 	Vice President and Controller
			
		 		 	Email Address:

 [Signature Page to Registration Rights Agreement] 

 Annex 1 

 

					
	 Selling Stockholder Name
	  	Shares to be Registered for Resale	 
	 SANTÉ HEALTH VENTURES ANNEX FUND, L.P.
	  	 	855,010	 
	 SANTÉ HEALTH VENTURES I, L.P.
	  	 	6,558,678	 
	 SHV MANAGEMENT SERVICES, LP
	  	 	50,000	 
	 LONGITUDE VENTURE PARTNERS III, L.P.
	  	 	937,500	 
	 CDK ASSOCIATES L.L.C.
	  	 	1,039,204

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]